CRS Products

36 Congressional Research Service reports and publications

Expiring Health Provisions of the 119th Congress
2025-09-24 · Reports · R48649 · HTML available · PDF available
Pandemic and All-Hazards Preparedness Act: An Overview
2025-08-07 · Resources · IF12683 · HTML available · PDF available
Science and Technology Issues for the 119th Congress
2025-04-03 · Reports · R48482 · HTML available · PDF available
H5N1 Avian Influenza: The Human Health Response
2025-03-12 · Resources · IF12895 · HTML available · PDF available
Organ Procurement and Transplantation: Administration, Oversight, and Policy Issues
2025-02-14 · Reports · R48426 · HTML available · PDF available
Emergency Federal Assistance for Extreme Heat: An Overview
2025-01-02 · Resources · IF12823 · HTML available · PDF available
Over-The-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization
2024-11-20 · Resources · IF12821 · HTML available · PDF available
The Federal Status of Marijuana and the Policy Gap with States
2024-05-02 · Resources · IF12270 · HTML available · PDF available
FDA Human Medical Product User Fee Programs
2024-04-26 · Reports · R44750 · HTML available · PDF available
Emergency Response to Extreme Heat: Federal Financial Assistance and Considerations for Congress
2024-04-09 · Reports · R46873 · HTML available · PDF available
The Orphan Drug Act: Legal Overview and Policy Considerations
2024-03-05 · Resources · IF12605 · HTML available · PDF available
PREVENT Pandemics Act (P.L. 117-328, Division FF, Title II)
2023-08-15 · Reports · R47649 · HTML available · PDF available
Xylazine: Considerations for Federal Control
2023-08-01 · Posts · IN12086 · HTML available
Medical Product Regulation: Drugs, Biologics, and Devices
2023-05-26 · Resources · IF11083 · HTML available · PDF available
Insulin Coverage Under Private Health Insurance and Medicare Part D: In Brief
2023-02-06 · Reports · R47409 · HTML available · PDF available
U.S. Domestic Response to the 2022 Monkeypox Outbreak
2022-08-05 · Resources · IF12186 · HTML available · PDF available
Infant Formula Shortage: FDA Regulation and Federal Response
2022-05-21 · Resources · IF12123 · HTML available · PDF available
Synthetic Nicotine: Frequently Asked Questions
2022-02-28 · Reports · R47043 · HTML available · PDF available
FDA Regulation of Over-the-Counter (OTC) Drugs: Overview and Issues for Congress
2021-12-10 · Reports · R46985 · HTML available · PDF available
Federal Emergency Declarations
2021-11-23 · Infographics · IG10029 · HTML available · PDF available
COVID-19 Testing: Frequently Asked Questions
2021-09-16 · Reports · R46481 · HTML available · PDF available
Health Equity and Disparities During the COVID-19 Pandemic: Brief Overview of the Federal Role
2021-07-28 · Reports · R46861 · HTML available · PDF available
FDA Regulation of Tobacco Products
2021-07-09 · Reports · R45867 · HTML available · PDF available
American Rescue Plan Act of 2021 (P.L. 117-2): Public Health, Medical Supply Chain, Health Services, and Related Provisions
2021-07-02 · Reports · R46834 · HTML available · PDF available
The Generic Drug User Fee Amendments (GDUFA): Background and Reauthorization
2021-04-29 · Reports · R46778 · HTML available · PDF available
Expanded Access and Right to Try: Access to Investigational Drugs
2021-03-16 · Reports · R45414 · HTML available · PDF available
Off-Label Use of Prescription Drugs
2021-02-23 · Reports · R45792 · HTML available · PDF available
Biologics and Biosimilars: Background and Key Issues
2019-06-06 · Reports · R44620 · HTML available · PDF available
FDA and Drug Prices: Facilitating Access to Generic Drugs
2019-01-17 · Resources · IF11075 · HTML available · PDF available
Drug Shortages: Causes, FDA Authority, and Policy Options
2018-12-27 · Resources · IF11058 · HTML available · PDF available
Emergency Use Authorization and FDA’s Related Authorities
2018-08-13 · Resources · IF10745 · HTML available · PDF available
How FDA Approves Drugs and Regulates Their Safety and Effectiveness
2018-05-08 · Reports · R41983 · HTML available · PDF available
Prescription Drug User Fee Act (PDUFA): 2017 Reauthorization as PDUFA VI
2018-03-16 · Reports · R44864 · HTML available · PDF available
FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development
2018-03-16 · Reports · R44810 · HTML available · PDF available
Animal Drug User Fee Programs
2018-01-12 · Reports · R45077 · HTML available · PDF available
Drug Compounding: FDA Authority and Possible Issues for Congress
2018-01-05 · Reports · R45069 · HTML available · PDF available